News

Tokyo, Japan and Cambridge, UK, 11 January 2021 – Sosei Group Corporation (“the Company”; TSE: 4565), today announced its Chief Financial Officer, Chris Cargill, will present at the 39th Annual J.P. Morgan Healthcare Conference, which will take place virtually, on Thursday, 14 January 2021.

A new way for Cambridge businesses and research institutions to connect to key sites and communities across Europe is now available thanks to Light Blue Fibre, bandwidth infrastructure provider euNetworks, and the UK Innovation Corridor’s most advanced data centre, Kao Data.


Light Blue Fibre, which was launched as a joint venture by University of Cambridge and Cambridgeshire County Council in 2019 is now being enabled by euNetworks, which specialises in data-centre-to-data-centre connectivity across the UK and Europe.

Cambridge, UK, 11 January 2021: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration.

With facilities already in Shanghai and Beijing, Biocair recently announced the opening of its new office in Guangzhou.


Strategically located close to Guangzhou Airport, the new office improves operational capacity, and employs a team of logistics experts with comprehensive knowledge of the local customer base, transport network and import / export regulations. Temperature-controlled vehicles will join Biocair China’s existing fleet to provide efficient, secure and compliant transportation for time and temperature-sensitive biological materials.

NORWICH, UK – 07 January 2021: Leaf Expression Systems (Leaf), a contract development and manufacturing organisation based in Norwich, UK, has announced today that it has produced three further products to support research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) pandemic.

The products developed include:

Find out what we're up to in this month's edition of eNews here


AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.

These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates.

Cambridge 04 January 2021: Babraham Bioscience Technologies Ltd (BBT), the organisation which oversees the development and day-to-day management of the Babraham Research Campus is pleased to welcome three new members to its board.

Stevenage, UK – 31 December 2020


Dr Sally Ann Forsyth, CEO of Stevenage Bioscience Catalyst (SBC), thanks her colleagues and collaborators after being honoured in the 2021 New Year Honours list. Sally Ann has been awarded an Officer of the Order of the British Empire (OBE) for services to business and science.

Issue 12 / December 2020

Latest legal newsletter from Mills & Reeve - Regulatory framework for medicines and medical devices as we reach the end of the transition period for leaving the EU, AI and healthtech and more, including recordings from Genesis 2020 (Taking a UK Private company to Nasdaq) and the latest Legal Forum.


https://update.mills-reeve.com/12/2613/december-2020/life-sciences---seq...


Pages